Market Overview:
The global hormonal contraceptive market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing awareness about contraception, rising prevalence of sexually transmitted infections (STIs), and technological advancements in the field of contraception. The oral contraceptive pills segment is expected to dominate the global hormonal contraceptive market during the forecast period owing to its high adoption rate and ease of use. Injectable birth control is projected to be the fastest-growing segment during the forecast period, owing to its advantages such as long-term efficacy, convenience, and affordability. Geographically, North America dominates the global hormonal contraceptive market followed by Europe and Asia Pacific. The growth in these regions can be attributed to factors such as increasing awareness about contraception methods among women, rising prevalence of STIs, and growing demand for advanced contraceptives technologies.
Product Definition:
A hormonal contraceptive is a type of birth control that uses hormones to prevent pregnancy. Hormonal contraceptives come in many forms, including pills, patches, injections, and vaginal rings. They work by preventing the release of an egg from the ovary (ovulation), making it difficult for sperm to reach the egg, and thickening cervical mucus so sperm can't enter the uterus.
Oral Contraceptive Pills:
Oral contraceptive pills are a group of birth control products that include ethinyl estradiol and progesterone. These drugs act by preventing the release of an egg from the ovary. The pill has an effect only if taken regularly and as prescribed by a doctor, otherwise it is not effective. They do not protect against sexually transmitted diseases such as AIDS or other infections.
Injectable Birth Control:
Injectable birth control is a man-made hormonal contraceptive that contains estrogen and progesterone. It's an Intravenous drug delivery system, which works by preventing implantation (the process in which the fertilized egg would attach to the uterus) of pregnancy.
The main factor responsible for high adoption of Injectable birth control is its quick effect on compared to oral pills or implants.
Application Insights:
The household application segment led the market and accounted for more than 54% share of the global revenue in 2017. The rising awareness about hormonal contraceptives among all age groups is expected to be a key factor driving the demand in this segment over the forecast period. Furthermore, easy availability of methods through retail pharmacies coupled with high product satisfaction is anticipated to further drive demand from households over next few years.
The clinics application segment was valued at USD 2,176.9 million in 2017 owing to increasing utilization of these products by doctors as an alternative method for birth control instead of using condoms or other forms of contraception that are available at minimal cost and without any medical complications.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in awareness about contraceptives, high purchasing power, and availability of a wide range of products. Moreover, an increase in the number of FDA approvals for new hormonal contraceptive drugs is also expected to drive growth during the forecast period. The U.S., which accounted for more than 80% share in North America market, is one of the most developed countries regarding healthcare facilities along with having high purchasing power individuals.
Asia Pacific region is expected to witness lucrative growth over the coming years due to rising population.
Growth Factors:
- Increasing awareness about contraception and its benefits
- Rise in number of women in the workforce
- Government initiatives to promote use of contraceptives among women
- Growing popularity of long-term contraception methods such as IUDs and implants
- Increased focus on sexual health and reproductive rights
Scope Of The Report
Report Attributes
Report Details
Report Title
Hormonal Contraceptive Market Research Report
By Type
Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches
By Application
Hospitals, Household, Clinics
By Companies
Ansell Limited, Bayer AG, Church and Dwight Co, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer, Teva Pharmaceutical Industries, The Female Health Company, Organon International, Afaxys
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Hormonal Contraceptive Market Report Segments:
The global Hormonal Contraceptive market is segmented on the basis of:
Types
Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Household, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ansell Limited
- Bayer AG
- Church and Dwight Co
- Johnson and Johnson
- Mayer Laboratories
- Merck and Co
- Mylan N.V.
- Pfizer
- Teva Pharmaceutical Industries
- The Female Health Company
- Organon International
- Afaxys
Highlights of The Hormonal Contraceptive Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Contraceptive Pills
- Injectable Birth Control
- Emergency Contraceptive Pills
- Vaginal Rings
- Transdermal Patches
- By Application:
- Hospitals
- Household
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hormonal Contraceptive Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hormonal contraceptives are a type of birth control that work by stopping the ovaries from releasing an egg. This can prevent pregnancy. There are many different types of hormonal contraceptives, each with its own set of benefits and drawbacks. The most common types are the pill, patch, ring, and shot.
Some of the major players in the hormonal contraceptive market are Ansell Limited, Bayer AG, Church and Dwight Co, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer, Teva Pharmaceutical Industries, The Female Health Company, Organon International, Afaxys.
The hormonal contraceptive market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hormonal Contraceptive Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hormonal Contraceptive Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hormonal Contraceptive Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hormonal Contraceptive Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hormonal Contraceptive Market Size & Forecast, 2020-2028
4.5.1 Hormonal Contraceptive Market Size and Y-o-Y Growth
4.5.2 Hormonal Contraceptive Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral Contraceptive Pills
5.2.2 Injectable Birth Control
5.2.3 Emergency Contraceptive Pills
5.2.4 Vaginal Rings
5.2.5 Transdermal Patches
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Household
6.2.3 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hormonal Contraceptive Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hormonal Contraceptive Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral Contraceptive Pills
9.6.2 Injectable Birth Control
9.6.3 Emergency Contraceptive Pills
9.6.4 Vaginal Rings
9.6.5 Transdermal Patches
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Household
9.10.3 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral Contraceptive Pills
10.6.2 Injectable Birth Control
10.6.3 Emergency Contraceptive Pills
10.6.4 Vaginal Rings
10.6.5 Transdermal Patches
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Household
10.10.3 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral Contraceptive Pills
11.6.2 Injectable Birth Control
11.6.3 Emergency Contraceptive Pills
11.6.4 Vaginal Rings
11.6.5 Transdermal Patches
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Household
11.10.3 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral Contraceptive Pills
12.6.2 Injectable Birth Control
12.6.3 Emergency Contraceptive Pills
12.6.4 Vaginal Rings
12.6.5 Transdermal Patches
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Household
12.10.3 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral Contraceptive Pills
13.6.2 Injectable Birth Control
13.6.3 Emergency Contraceptive Pills
13.6.4 Vaginal Rings
13.6.5 Transdermal Patches
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Household
13.10.3 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hormonal Contraceptive Market: Competitive Dashboard
14.2 Global Hormonal Contraceptive Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ansell Limited
14.3.2 Bayer AG
14.3.3 Church and Dwight Co
14.3.4 Johnson and Johnson
14.3.5 Mayer Laboratories
14.3.6 Merck and Co
14.3.7 Mylan N.V.
14.3.8 Pfizer
14.3.9 Teva Pharmaceutical Industries
14.3.10 The Female Health Company
14.3.11 Organon International
14.3.12 Afaxys
